Oaklander welcomed the news of the approval of the new vaccine, saying that more adults should be vaccinated against shingles. In the United States alone, there are an estimated 1 million cases of shingles a year, and one in three people can expected to develop the condition during their lifetime.
6 brokerages have issued twelve-month price objectives for Arbutus Biopharma Corp's shares. Their forecasts range from $5.00 to $10.00. On average, they anticipate Arbutus Biopharma Corp's stock price to reach $7.00 in the next year.
MarketWatch News on SGMO. 1  S&P 500 breaks from the range, Nasdaq presses uncharted territory (again) 11:38 a.m. 2  Sangamo BioSciences downgraded to neutral from outperform at Wedbush Securities. 3  Sangamo BioSciences stock price target cut to $4 from $30 at Wedbush Securities.  Dozens of biotech companies are âfreeâ for investorsâ taking.